Skip to content
TrialScanner

NCT03205995

Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome

Phase 3TerminatedOMERLead

Registry record

Lead sponsor
Omeros Corporation
Conditions
Thrombotic Microangiopathies; Atypical Hemolytic Uremic Syndrome
Primary completion
Feb 2, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03205995 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03205995: Safety and Efficacy Study of... | TrialScanner